MedPath

IMMUNOE RESEARCH CENTERS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection

Phase 4
Conditions
Post-Viral Fatigue Syndrome
Post-Viral Disorder (Disorder)
Covid19
Interventions
First Posted Date
2021-01-12
Last Posted Date
2021-01-12
Lead Sponsor
IMMUNOe Research Centers
Target Recruit Count
40
Registration Number
NCT04705831
Locations
🇺🇸

IMMUNOe Research Centers, Centennial, Colorado, United States

A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions

Phase 4
Completed
Conditions
CVI - Common Variable Immunodeficiency
Interventions
Biological: C1-esterase inhibitor [recombinant] (C1-INH-R)
First Posted Date
2018-07-03
Last Posted Date
2021-02-15
Lead Sponsor
IMMUNOe Research Centers
Target Recruit Count
20
Registration Number
NCT03576469
Locations
🇺🇸

IMMUNOe Research Centers, Centennial, Colorado, United States

A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Phase 4
Conditions
Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
Pediatric Acute-Onset Neuropsychiatric Syndrome
Interventions
Biological: IVIG
First Posted Date
2017-11-21
Last Posted Date
2019-11-19
Lead Sponsor
IMMUNOe Research Centers
Target Recruit Count
21
Registration Number
NCT03348618
Locations
🇺🇸

IMMUNOe Research Centers, Centennial, Colorado, United States

🇺🇸

Midwest Pediatrics, Papillion, Nebraska, United States

🇺🇸

Allergy, Asthma & Immunology Relief Research Institute, Charlotte, North Carolina, United States

The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations

Completed
Conditions
Primary Immunodeficiency
First Posted Date
2017-11-13
Last Posted Date
2017-11-13
Lead Sponsor
IMMUNOe Research Centers
Target Recruit Count
15
Registration Number
NCT03339778
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy